# Butrans for Treatment of Restless Legs Syndrome

> **NCT02138357** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** buprenorphine transdermal delivery system (BTDS)
- **DRUG:** Placebo for BTDS patch

## Key facts

- **NCT ID:** NCT02138357
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02138357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02138357, "Butrans for Treatment of Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02138357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*